Table 4.
HI titers specific for all three influenza strains included in the vaccine.
| Vaccination group | TIV | FluGEM-A | ||||||
|---|---|---|---|---|---|---|---|---|
| HI GEOMETRIC MEAN TITERS AND RATIO TO BASELINE TITERS | ||||||||
| Study day | 0 | 21 | 42 | 210 | 0 | 21 | 42 | 210 |
| Influenza B strain | ||||||||
| Number of subjects | 13 | 13 | 13 | 13 | 10 | 10 | 10 | 10 |
| HI GMT | 10.5 | 29.9 | 32.4 | 50.6 | 8.5 | 48.1 | 47.8 | 63.9 |
| HI GMT ratio | 1.0 | 2.8 | 3.1 | 4.8 | 1.0 | 5.7 | 5.6 | 7.6 |
| Influenza H1N1 strain | ||||||||
| Number of subjects | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 |
| HI GMT | 10.4 | 49.5 | 53.8 | 40.8 | 23.2 | 118.0 | 109.9 | 131.7 |
| HI GMT ratio | 1.0 | 4.8 | 5.2 | 3.9 | 1.0 | 5.1 | 4.7 | 5.7 |
| Influenza H3N2 strain | ||||||||
| Number of subjects | 15 | 15 | 15 | 15 | 12 | 12 | 12 | 12 |
| HI GMT | 13.2 | 197.2 | 243.7 | 179.5 | 23.1 | 261.9 | 287.0 | 244.3 |
| HI GMT ratio | 1.0 | 14.9 | 18.5 | 13.6 | 1.0 | 11.3 | 12.4 | 10.6 |
HI titers were measured on study days 0 (baseline) 21, 42, and 210.